Drug Repurposing to Treat Glucocorticoid Resistance in Asthma is a research paper published in Journal of Personalized Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 HL127332
National Institutes of Health
Grant: R01 HL129935
National Institutes of Health
Grant: U01 HL65899
National Institutes of Health
Grant: R01 NR13391
National Institutes of Health
Grant: P01 HL132825
National Institutes of Health
Grant: R01 HL139496
National Institutes of Health
Grant: R01 HL125734
Thrasher Research Fund
Grant: 15115
NHLBI NIH HHS
Grant: K23 HL151819
NIAID NIH HHS
Grant: L40 AI138248
NCATS NIH HHS
Grant: UL1 TR001863
National Institutes of Health
Grant: 5R01HL129935-02
DISEASE AND HEALTH: ASTHMA RESILIENCE THROUGH MICRORNA ATTRIBUTES (DHARMA)
National Institutes of Health
Grant: 5R01HL139496-03
MicroRNA-10a in Airway Smooth Muscle and Asthma
National Institutes of Health
Grant: 5U01HL065899-06
Pharmacogenetics of Asthma Treatment
National Institutes of Health
Grant: 5R01NR013391-02
GENOMICS AND PHARMACOGENOMICS OF SYMPTOMS IN ASTHMA
National Institutes of Health
Grant: 5P01HL132825-05
Systems Biology of Airway Disease
National Institutes of Health
Grant: 1R01HL127332-01
MICRORNAS IN CIRCULATION: ONTOLOGIES OF ASTHMA SEVERITY AND TREATMENT (MICROCOAST)
National Institutes of Health
Grant: 5R01HL125734-02
MICRORNAS AND EARLY LIFE EXPOSURES IN THE DEVELOPMENTAL ORIGIN OF ASTHMA
FWCI
1.37
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals